Walgreens agreed to pay the United States $300M, plus interest at a rate of 4.00% per annum accruing from October 20, 2024, of which $150M shall constitute restitution, to resolve False Claims Act allegations. Th settlement is neither an admission of liability by Walgreens nor a concession by the United States that its claims are not well founded, according to a court filing.
Discover outperforming stocks and invest smarter with Top Smart Score Stocks.
Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WBA:
Disclaimer & DisclosureReport an Issue
Arrowhead CFO Ken Myszkowski to retire, Daniel Apel to succeed
Hold Rating on Walgreens Boots Alliance Amid Mixed Performance and Acquisition Uncertainty
With a growing share of insurance executives viewing generative artificial intelligence as a tool for streamlining and improving functions like fraud detection, Deloitte predicts that AI technolog...